Azenta, Inc. (NASDAQ:AZTA – Get Free Report) has been given a consensus rating of “Hold” by the seven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $41.20.
A number of analysts recently commented on AZTA shares. Weiss Ratings upgraded shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. Wall Street Zen downgraded shares of Azenta from a “buy” rating to a “hold” rating in a research note on Sunday, October 18th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $37.00 target price on shares of Azenta in a report on Monday, September 14th.
View Our Latest Stock Report on Azenta
Institutional Investors Weigh In On Azenta
Azenta Trading Up 4.8%
Shares of AZTA stock opened at $39.16 on Friday. Azenta has a twelve month low of $15.93 and a twelve month high of $46.41. The company has a market capitalization of $1.72 billion, a P/E ratio of -14.19 and a beta of 1.47. The business’s 50 day moving average is $35.32 and its two-hundred day moving average is $28.47.
Azenta (NASDAQ:AZTA – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%. The firm had revenue of $161.18 million during the quarter, compared to analyst estimates of $149.31 million.
Azenta Company Profile
Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.
The company’s portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.
Featured Stories
- Five stocks we like better than Azenta
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
- MarketBeat Week in Review – 11/2 – 11/6
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
